Cargando…
Sulindac has strong antifibrotic effects by suppressing STAT3-related miR-21
Pulmonary fibrosis (PF) is a disease with an unknown cause and a poor prognosis. In this study, we aimed to explore the pathogenesis of PF and the mechanism of sulindac in attenuating bleomycin (BLM)-induced PF. The rat PF model was induced by BLM and verified through histological studies and hydrox...
Autores principales: | Zhou, Xue, Li, You-Jie, Gao, Shu-Yan, Wang, Xiao-Zhi, Wang, Ping-Yu, Yan, Yun-Fei, Xie, Shu-Yang, Lv, Chang-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4420612/ https://www.ncbi.nlm.nih.gov/pubmed/25704671 http://dx.doi.org/10.1111/jcmm.12506 |
Ejemplares similares
-
Inhibition of breast cancer cell motility with a non-cyclooxygenase inhibitory derivative of sulindac by suppressing TGFβ/miR-21 signaling
por: Yi, Bin, et al.
Publicado: (2016) -
miR299a-5p promotes renal fibrosis by suppressing the antifibrotic actions of follistatin
por: Mehta, Neel, et al.
Publicado: (2021) -
Selenium and sulindac are synergistic to inhibit intestinal tumorigenesis in Apc/p21 mice
por: Bi, Xiuli, et al.
Publicado: (2013) -
Chemoprevention of Colon Cancer by DFMO, Sulindac, and NO-Sulindac Administered Individually or in Combinations in F344 Rats
por: Madka, Venkateshwar, et al.
Publicado: (2023) -
miR-4293 upregulates lncRNA WFDC21P by suppressing mRNA-decapping enzyme 2 to promote lung carcinoma proliferation
por: Zhang, Qian, et al.
Publicado: (2021)